News
March 14, 2022 Event
Oblique Therapeutics AB (publ.) will be at the Pharma Partnering Summit
12th and 13th May 2022 - Brussels
March 7, 2022 Event
Thrilled to take part as Expert Speaker to the next DDN event
21st- 22nd April 2022- Philadelphia - USA
February 28, 2022 Event
Oblique Therapeutics AB (publ.) will be attending to BIO-Europe Spring 2022
online event from March 28th -31.
February 4, 2022 News
We are hiring- Laboratory Engineer
Location: Gothenburg
January 20, 2022 Event
Oblique Therapeutics AB (publ.)will join the BiotechGate Digital Partnering
7-11 Feb 2022.
January 14, 2022 News
Oblique Therapeutics AB (publ.) is pleased to announce that the United States Patent and Trademark Office
has granted a patent for its innovative AbiProt® technology
December 31, 2021 Event
Oblique’s Therapeutics AB (publ.) presentation at the virtual J.P. Morgan Healthcare Conference
scheduled for Monday, January 10, 2022
December 6, 2021 News
Award – Oblique Therapeutics AB (publ.) a Top Immunotherapy solution providers
in Europe 2021
November 25, 2021 News
Oblique Therapeutic’s AB (publ.) interim report for
January – September 2021 (Q3 2021) is available.
November 18, 2021 Event
Oblique Therapeutics AB (publ.) will be at the 3rd RAS/MAPK Pathway Targeted Drug Discovery Summit
February 22- 24, 2022 Boston MA